These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34635148

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.
    Hijazi G, Paschall A, Young SP, Smith B, Case LE, Boggs T, Amarasekara S, Austin SL, Pendyal S, El-Gharbawy A, Deak KL, Muir AJ, Kishnani PS.
    Mol Genet Metab Rep; 2021 Dec; 29():100821. PubMed ID: 34820282
    [Abstract] [Full Text] [Related]

  • 44. Glycogen storage disease type Ia: frequency and clinical course in Turkish children.
    Saltik IN, Ozen H, Ciliv G, Koçak N, Yüce A, Gürakan F, Dinler G.
    Indian J Pediatr; 2000 Jul; 67(7):497-501. PubMed ID: 10957834
    [Abstract] [Full Text] [Related]

  • 45. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure.
    Davis MK, Weinstein DA.
    Pediatr Transplant; 2008 Mar; 12(2):137-45. PubMed ID: 18307661
    [Abstract] [Full Text] [Related]

  • 46. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI, Crigler JF.
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [Abstract] [Full Text] [Related]

  • 47. Neurological Characteristics of Pediatric Glycogen Storage Disease.
    Muzetti JH, do Valle DA, Santos MLSF, Telles BA, Cordeiro ML.
    Front Endocrinol (Lausanne); 2021 Aug; 12():685272. PubMed ID: 34093448
    [Abstract] [Full Text] [Related]

  • 48. Novel variants in Turkish patients with glycogen storage disease.
    Çakar NE, Gezdirici A, Topuz HŞ, Önal H.
    Pediatr Int; 2020 Oct; 62(10):1145-1150. PubMed ID: 32374048
    [Abstract] [Full Text] [Related]

  • 49. Is there any difference in anesthetic management of biliary atresia and glycogen storage disease patients undergoing liver transplantation?
    Jawan B, Tseng CC, Chen YS, Wang CC, Cheng YF, Huang TL, Eng HL, Chiu KW, Wang SH, Lin CC, Lin TS, Liu YW, Chen CL.
    J Surg Res; 2005 Jun 01; 126(1):82-5. PubMed ID: 15916979
    [Abstract] [Full Text] [Related]

  • 50. Living donor liver transplantation for post-Kasai biliary atresia: Analysis of pretransplant predictors of outcomes in infants.
    Kitajima T, Sakamoto S, Sasaki K, Uchida H, Narumoto S, Fukuda A, Teramukai S, Uemoto S, Kasahara M.
    Liver Transpl; 2017 Sep 01; 23(9):1199-1209. PubMed ID: 28590589
    [Abstract] [Full Text] [Related]

  • 51. Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational study.
    Overduin RJ, Venema A, Lubout CMA, Fokkert-Wilts MJ, De Boer F, Schreuder AB, Rossi A, Derks TGJ.
    Mol Genet Metab; 2024 Sep 01; 143(1-2):108573. PubMed ID: 39243574
    [Abstract] [Full Text] [Related]

  • 52. Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases.
    Liang Y, Du C, Wei H, Zhang C, Zhang M, Hu M, Fang F, Luo X.
    Mol Genet Genomic Med; 2020 Oct 01; 8(10):e1444. PubMed ID: 32772503
    [Abstract] [Full Text] [Related]

  • 53. Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation: a case-control study.
    Elizabeth Parsons C, Nelson R, Book LS, Kyle Jensen M.
    Liver Transpl; 2014 Dec 01; 20(12):1468-74. PubMed ID: 25179803
    [Abstract] [Full Text] [Related]

  • 54. Reduced-size liver transplantation for glycogen storage disease.
    Ji HF, Wang WL, Shen Y, Zhang M, Liang TB, Wu J, Xu X, Yan S, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2009 Feb 01; 8(1):106-8. PubMed ID: 19208526
    [Abstract] [Full Text] [Related]

  • 55. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
    Dale DC, Bolyard AA, Marrero T, Kelley ML, Makaryan V, Tran E, Leung J, Boxer LA, Kishnani PS, Austin S, Wanner C, Ferrecchia IA, Khalaf D, Maze D, Kurtzberg J, Zeidler C, Welte K, Weinstein DA.
    Curr Opin Hematol; 2019 Jan 01; 26(1):16-21. PubMed ID: 30451720
    [Abstract] [Full Text] [Related]

  • 56. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.
    Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, Raiman J, Schulze A, Siriwardena K, Mercimek-Mahmutoglu S.
    Mol Genet Metab; 2014 Nov 01; 113(3):171-6. PubMed ID: 25266922
    [Abstract] [Full Text] [Related]

  • 57. Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib.
    Du C, Li Z, Wei H, Zhang M, Hu M, Zhang C, Luo X, Liang Y.
    BMC Med Genomics; 2021 Mar 17; 14(1):81. PubMed ID: 33731098
    [Abstract] [Full Text] [Related]

  • 58. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY, Matern D, Mansfield BC, Chen YT.
    Curr Mol Med; 2002 Mar 17; 2(2):121-43. PubMed ID: 11949931
    [Abstract] [Full Text] [Related]

  • 59. Diagnosis and follow-up of glycogen storage disease (GSD) type VI from the largest GSD center in China.
    Luo X, Duan Y, Fang D, Sun Y, Xiao B, Zhang H, Han L, Liang L, Gong Z, Gu X, Yu Y, Qiu W.
    Hum Mutat; 2022 May 17; 43(5):557-567. PubMed ID: 35143115
    [Abstract] [Full Text] [Related]

  • 60. Renal Function Parameters and Serum Sodium Enhance Prediction of Wait-List Outcomes in Pediatric Liver Transplantation.
    Thalji L, Thalji NM, Heimbach JK, Ibrahim SH, Kamath PS, Hanson A, Schulte PJ, Haile DT, Kor DJ.
    Hepatology; 2021 Mar 17; 73(3):1117-1131. PubMed ID: 32485002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.